Belarusian nanotechnologies of Chinese assembly
With the production of a product that has no analogues in the Russian market, only one business proposal was associated.
An innovative project is a stretchable concept. If we evaluate the projects presented by SBAR, a quarter of them involved the organization of new sales methods, another quarter — new productions of existing products, another quarter represented scientific ideas at the zero stage, and only the remaining part was associated with the release and promotion of real products and technologies to the market.
Yulia Rudenko, an entrepreneur from Moscow, asked for investments to install vending machines for women's tights. In business centers. According to Ms. Rudenko, the "office ladies" have tights torn at the most inopportune moment, right at the workplace, and even at the beginning of the working day. Automatic machines would help solve the urgent problem of ladies.
Then, at the presentation, it was time for nanotechnology. Minsk entrepreneur Igor Zygmantovich offered business angels to invest in the organization of the production of magnetic cores based on amorphous and nanocrystalline alloys with cobalt or iron additives. These wires, used, for example, in current transformers, reduce electricity losses by four percent compared to analogues made of electrical steel. According to Zygmantovich, the volume of production of magnetic cores in Russia is 350 tons per year, and the demand is already 600 tons. In addition, in Russia, nanoalloys as a material for magnetic circuits have displaced electrical steel by only one percent, and in developed countries their share already reaches 20 percent.
Mr. Zygmantovich proposed to invest in the purchase of installations for the production of magnetic cores ... in China, and to open the production itself in Belarus. The entrepreneur refused to name the manufacturer from China, referring to the fact that "it was very difficult to find him." To the question from the audience, "Won't transformer factories buy these installations from the same manufacturer and organize the production of such nanowires for themselves?" the businessman simply replied: "Why? They will buy finished products from us." The idea to organize the production of wires for export to Russia in the possession of Batsky caused potential investors to be no less wary. Igor Zygmantovich was reminded of the notorious "factor of Belarus".
The greatest interest of the audience was aroused by the project of a light tracked motorcycle-all-terrain vehicle, presented by Eduard Gerashchenko. The mini-all-terrain vehicle can reach speeds of up to 45 kilometers per hour, carry 140 kilograms of cargo and drive without getting stuck, even on mudslides and gullies, even on debris from branches, even on deep snow. That, according to the author of the project, neither ATVs, nor wheeled motorcycles of increased cross-country ability, nor even snowmobiles, can. All the participants were convinced of the above-mentioned capabilities of the ATV by watching the video: the current prototype was already assembled by entrepreneurs-engineers led by Eduard Gerashchenko. The businessman-innovator asked for 800 thousand dollars to organize the production of two hundred cars per year for eight to ten months. Mr. Gerashchenko estimated the price of "toys for hunters" at about six to nine thousand dollars, the return on investment - in one year, and the rate of return — at a huge 70-90 percent. The developers have already filed an application for a Russian patent.
Ruslan Ilyuk, the head of the department of therapy of patients with addictive pathology of the V.M. Bekhterev Psychological Institute from St. Petersburg, was the last "to see" business angels. The scientist presented a project of a fundamentally new drug for alcoholism developed jointly with colleagues at the Institute. According to Mr. Ilyuk, all existing clinical drugs either have low efficacy or cause side effects up to hallucinations. However, apart from the scientific idea, the researcher did not present anything. And for the entire complex of preclinical and clinical trials, he asked for no less than... seven million euros. Although he made a reservation that after success in preclinical trials and in the first phase of clinical trials, "large pharmaceutical companies can pick up the project." One of those present decided on the question: "You say that existing drugs are either ineffective or have serious side effects. And where is the guarantee that your future drug will not have them?". The medical scientist answered confidently: "The formula of the active substance inspires us as developers with optimism!". The presentation session ended with a friendly burst of laughter.
Portal "Eternal youth" www.vechnayamolodost.ru01.11.2008